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Formulations should carry the quality designed into the products to meet the pharmaceutical 
requirements. The Quality by Design (QbD) approach ensures the quality of medicines by developing 
and manufacturing products following statistics-, analytics- and risk-management-based 
methodologies [1]. 
This research aims to systematise the characteristics of the components (material attributes, MAs) and 
the preparation settings (process parameters, PPs) in case of the thin-film hydration liposome 
preparation technique. Furthermore, the study specifies the quality target product profile of a 
liposomal formulation and the critical quality attributes of the liposomes. Also, it identifies those MAs 
and PPs that influence the characteristics of the vesicles [2]. 
The theory was supported with practical research; the effect of the working temperature, the 
phosphatidylcholine-cholesterol ratios, the PEGylated phospholipid concentration, the type of the 
hydration media and the cryoprotectants were studied in different formulations. The results present 
the key points of a Risk Assessment (RA)-based experimental design, and the impacts of the critical 
factors mentioned above based on the investigation of the liposomal characteristics (size, surface 
charge, thermodynamic behaviours and structural investigations). 
The study revealed the relevance of the QbD-based RA in the thin-film hydration-based liposome 
preparation process and shown the main effects of the tested critical factors. The results ensure that 
the understanding and the application of the QbD elements in the pharmaceutical developments help 
to influence and to reach the aimed quality of the formulated product. 
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